Date: Tuesday, October 19, 2021
Time: 11:00 am
Talk Title: Bacterial superglues and nano-assemblies to tickle the immune system
Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and nanotechnology to understand receptor trafficking. He has been a PI at Oxford since 2007. In 2017 he was awarded the Royal Society of Chemistry Norman Heatley Prize for chemical biology. He is a founder of SpyBiotech, which is now running clinical trials for a Covid-19 vaccine, and Director of Entrepreneurship for the Biochemistry Department. His work has been funded by ERC, BBSRC, EPSRC, MRC, Wellcome Trust and through collaborations with companies including AB Vista, QinetiQ, Sekisui Diagnostics and Sony.